Medicus Pharma Ltd. effects 1-for-50 share consolidation effective October 12, 2026
Medicus Pharma Ltd. effected a 1-for-50 share consolidation of its issued and outstanding common shares, no par value, effective October 12, 2026, by filing Articles of Amendment with the Ontario Ministry of Public and Business Service Delivery. The consolidation was approved by shareholders at the June 3, 2026 Annual General and Special Meeting and unanimously approved by the Board at a 1-for-50 ratio on September 24, 2026. Proportionate adjustments were made to the exercise or conversion prices and the number...
Key takeaways
1-for-50 reverse share consolidation of common shares is effective October 12, 2026, with post-consolidation trading on Nasdaq from that date.
Shareholder approval was obtained at the June 3, 2026 Annual General and Special Meeting for a consolidation of up to 1-for-50.
Board set the 1-for-50 ratio by unanimous approval on September 24, 2026, and Articles of Amendment were filed with the Ontario Ministry of Public and Business Service Delivery.
Proportionate adjustments were applied to exercise/conversion prices and to the number of underlying common shares for outstanding equity awards, convertible securities, and warrants (MDCXW).
No fractional shares were issued; fractional shares were rounded down to the nearest whole common share with cash paid in lieu of fractional entitlements.
Common shares (MDCX) and warrants (MDCXW) remain registered on the Nasdaq Capital Market following the consolidation.
The 8-K was signed by Dr. Raza Bokhari, Executive Chairman and Chief Executive Officer of Medicus Pharma Ltd.
Disclosure changes
- Material Modification to Rights of Security Holders (Item 3.03)
Company effected a 1-for-50 share consolidation effective October 12, 2026 by filing Articles of Amendment with the Ontario Ministry of Public and Business Service Delivery; common shares began trading on a post-consolidation basis on the Nasdaq Capital Market the same day.
Reverse share splits reduce the number of outstanding shares and increase per-share price; proportionate adjustments to warrants, equity awards, and convertible securities affect per-share economics for holders. - Amendments to Articles of Incorporation (Item 5.03)
Articles of Amendment reflecting the 1-for-50 share consolidation were filed as Exhibit 3.1 and are effective October 12, 2026.
Articles of Amendment is the constitutive document governing share structure; investors can review Exhibit 3.1 for the full text.
Primary source
TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.
Open SEC filingFollow MDCX in real time
Get material earnings, filing, IR, and earnings-call alerts by email.